Form 8-K RIGEL PHARMACEUTICALS For: Jan 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Rigel Pharmaceuticals (RIGL) PT Raised to $11 at BMO Capital
January 23, 2019 1:15 PM ESTBMO Capital analyst Do Kim raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $11.00 (from $10.00) while maintaining a Outperform rating.
Kim commented, "We believe the signing of a European partner represents an important milestone, as it provides non-dilutive financing as well as additional... More



